Marcus & Millichap Q3 2026 Revenue Tops Estimates at $208.4M, but EPS Misses at $0.03
Revenue of $208.4M vs. $205.1M expected and adjusted EPS of $0.03 vs. $0.07; revenue up 7.5% from a year earlier.
Marcus & Millichap (MMI) posted mixed third-quarter 2026 results, with revenue above the estimate and adjusted EPS below it. Revenue was $208.4 million, up 7.5% from a year earlier, above the $205.1 million estimate, and adjusted EPS was $0.03, up 200% from a year earlier, below the $0.07 estimate.
Q3 2026 scorecard
| Parameters | Expected | Actual | Beat/Miss |
|---|---|---|---|
| Adjusted EPS | $0.07 | $0.03 | Miss by 54% |
| Revenue | $205.1M | $208.4M | Beat by 1.6% |
| Change | YoY | QoQ |
|---|---|---|
| Adjusted EPS | ▲ 200% | ▼ 70% |
| Revenue | ▲ 7.5% | ▲ 2.7% |
By our calculation, revenue was $3.3 million above the estimate and adjusted EPS was $0.04 below it. The QoQ column compares with the previous quarter's revenue of $202.9 million and adjusted EPS of $0.10. The YoY column compares with $193.9 million and $0.01 in the same quarter a year earlier.
Track record
- EPS record. Adjusted EPS beat the estimate in 5 of the last 8 reports, including this one.
- Revenue record. Revenue beat the estimate in 5 of the last 8 reports.
- Revenue trend. Revenue over the last 5 reports, oldest first: $193.9 million, $243.9 million, $171.5 million, $202.9 million and $208.4 million.
What to watch
- Next-quarter estimates. Consensus calls for EPS of $0.33 and revenue of $259.6 million next quarter, based on 2 analysts.
- Revenue growth. Whether revenue keeps growing from a year earlier after this quarter's 7.5% increase to $208.4 million.
- Estimate record. Whether Marcus & Millichap extends a record of beating EPS estimates in 5 of its last 8 reports.
- Related coverage. See our reports on Humana, Fluor, Kyivstar and National HealthCare.
Sources: Results are from Marcus & Millichap's Nov. 6, 2026 quarterly report. Estimates are consensus figures. The prior-quarter and year-ago comparison figures are from Marcus & Millichap's earlier quarterly reports. Items labeled by our calculation are our own arithmetic. This article is informational only and is not investment advice.
Readers also read
MarketCatalyst is not a registered investment advisor and does not manage client assets. Content on this platform is provided for informational and educational purposes only. It is not investment advice, and MarketCatalyst is not a stock-picking or trade-alert service. Trading stocks and options involves risk, including the possible loss of principal. Consider your own goals, time horizon, and risk tolerance, and consult a qualified financial advisor before making any investment decision.